Extending Shelf Life of Therapeutic Proteins with Hydroxylpropyl ß-Cyclodextrins - Mechanistic Understanding of Bevacizumab Stabilization

3/10/2020 14:30 - 15:05

  • Case study of KLEPTOSE® as an effective excipient in bevacizumab formulation
  • Does surface properties of surfactants and protein properties affect aggregation?
  • Mechanistic understanding of bevacizumab stabilization with KLEPTOSE®
  • Thermal and oxidative stability of KLEPTOSE® under stress conditions

Shiqi Hong, Senior biopharma scientist, Roquette